Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 7/2021

01-07-2021 | Endoscopy | Original Contributions

Incidence and Prognostic Factors for the Development of Symptomatic and Asymptomatic Marginal Ulcers After Roux-en-Y Gastric Bypass Procedures

Authors: Julian Süsstrunk, Lara Wartmann, Diana Mattiello, Thomas Köstler, Urs Zingg

Published in: Obesity Surgery | Issue 7/2021

Login to get access

Abstract

Introduction

Marginal ulcer (MU) is a serious complication after Roux-en-Y gastric bypass (RYGB) procedures. This study reports the incidence, risk factors, and treatment outcomes of symptomatic and incidentally, at routine endoscopy diagnosed, MU.

Methods

All patients undergoing RYGB procedures between 2013 and 2018 at a single center were included. Upper endoscopy was performed in case of symptoms and/or routinely 2 and 5 years postoperatively.

Results

In total, 568 patients (83.3% female) underwent RYGB procedure with a median age of 40 years and median initial body mass index of 41 kg/m2. The median time to follow-up was 2.99 years. Routine 2- and 5-year upper endoscopy was performed in 256 (55.3%) and 65 (38.0%) eligible patients, respectively. In 86 (15.1%) patients, MU was diagnosed at a median time of 14.2 months (4.58–26.2) postoperatively and 24.4% of patients with MU were asymptomatic. In total, 76.7% of MUs were located on the side of the Roux limb. 88.4% of MUs were treated conservatively; re-operation was necessary in 10 (11.6%) patients. Smoking and type 2 diabetes mellitus were the only independent risk factors for MU development in multivariate analysis with a hazard ratio of 2.65 and 1.18 (HbA1c per unit >6.0), respectively.

Conclusion

MU is a common complication after gastric bypass surgery with 25% of patients being asymptomatic. Follow-up routine endoscopy is recommended for early MU detection and subsequent accurate therapy, especially in patients with the independent risk factors smoking and type 2 diabetes mellitus.
Literature
1.
2.
Kothari SN, Borgert AJ, Kallies KJ, et al. Long-term (>10-year) outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2017;13(6):972–8.PubMedCrossRef
3.
Weiss AC, Parina R, Horgan S, et al. Quality and safety in obesity surgery-15 years of Roux-en-Y gastric bypass outcomes from a longitudinal database. Surg Obes Relat Dis Elsevier. 2016;12(1):33–40.PubMedCrossRef
4.
Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults (Cochrane review). Cochrane Collab. 2014;8:244.
5.
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29(3):782–95.PubMedCrossRef
6.
Edholm D, Svensson F, Näslund I, et al. Long-term results 11 years after primary gastric bypass in 384 patients. Surg Obes Relat Dis. 2013;9(5):708–13.PubMedCrossRef
7.
Flum D, Belle S, King W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.PubMedCrossRef
8.
Patel RA, Brolin RE, Gandhi A. Revisional operations for marginal ulcer after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(3):317–22.PubMedCrossRef
9.
Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.PubMedCrossRef
10.
Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc Other Interv Tech. 2007;21(7):1090–4.CrossRef
11.
Sapala JA, Wood MH, Sapala MA, et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505–16.PubMedCrossRef
12.
MacLean LD, Rhode BM, Nohr C, et al. Stomal ulcer after gastric bypass. J Am Coll Surg. 1997;185:1–7.PubMedCrossRef
13.
Capella JF, Capella RF. Staple disruption and marginal ulceration in gastric bypass procedures for weight reduction. Obes Surg. 1996;6(1):44–9.PubMedCrossRef
14.
Wennerlund J, Gunnarsson U, Strigård K, et al. Acid-related complications after laparoscopic Roux-en-Y gastric bypass: risk factors and impact of proton pump inhibitors. Surg Obes Relat Dis. 2020;16(5):620–5.PubMedCrossRef
15.
Dittrich L, Schwenninger MV, Dittrich K, et al. Marginal ulcers after laparoscopic Roux-en-Y gastric bypass: analysis of the amount of daily and lifetime smoking on postoperative risk. Surg Obes Relat Dis. 2020;16(3):389–96.PubMedCrossRef
16.
Schulman AR, Abougergi MS, Thompson CC. H. pylori as a predictor of marginal ulceration: a nationwide analysis. Obesity. 2017;25(3):522–6.PubMedCrossRef
17.
Coblijn UK, Lagarde SM, de Castro SMM, et al. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25(5):805–11.PubMedCrossRef
18.
Azagury DE, Abu Dayyeh BK, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43(11):950–4.PubMedCrossRef
19.
Sverden E, Mattsson F, Sonden A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.PubMedCrossRef
20.
Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.PubMedCrossRef
21.
Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359(9300):14–22.PubMedCrossRef
22.
Clapp B, Hahn J, Dodoo C, et al. Evaluation of the rate of marginal ulcer formation after bariatric surgery using the MBSAQIP database. Surg Endosc. 2019;33(6):1890–7.PubMedCrossRef
23.
Yang CS, Lee WJ, Wang HH, et al. The influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg. 2006;16(6):735–9.PubMedCrossRef
24.
Rawlins L, Rawlins MP, Brown CC, et al. Effect of Helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(5):760–4.PubMedCrossRef
25.
Edholm D, Ottosson J, Sundbom M. Importance of pouch size in laparoscopic Roux-en-Y gastric bypass: a cohort study of 14,168 patients. Surg Endosc Springer US. 2016;30(5):2011–5.PubMedCrossRef
26.
Bendewald FP, Choi JN, Blythe LS, et al. Comparison of hand-sewn, linear-stapled, and circular-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2011;21(11):1671–5.PubMedCrossRef
27.
Wu Chao Ying V, Song SH, Khan JK, et al. Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies. Surg Endosc. 2015;29(5):1018–23.CrossRef
28.
Coblijn UK, Lagarde SM, De Castro SMM, et al. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study. Surg Obes Relat Dis. 2016;12(2):246–52.PubMedCrossRef
29.
Kang X, Zurita-Macias L, Hong D, et al. A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(5):1003–7.PubMedCrossRef
30.
Schulman AR, Chan WW, Devery A, et al. Opened proton pump inhibitor capsules reduce time to healing compared with intact capsules for marginal ulceration following Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol. 2017;15(4):494–500.e1.PubMedCrossRef
31.
Steinemann DC, Bueter M, Schiesser M, et al. Management of anastomotic ulcers after Roux-en-Y gastric bypass: results of an international survey. Obes Surg. 2014;24(5):741–6.PubMedCrossRef
32.
Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2(4):460–3.PubMedCrossRef
33.
Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.PubMedCrossRef
34.
El-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned? Surg Endosc. 2012;26(10):2789–96.PubMedCrossRef
35.
Moon RC, Teixeira AF, Goldbach M, et al. Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center. Surg Obes Relat Dis. 2014;10(2):229–34.PubMedCrossRef
36.
Pyke O, Yang J, Cohn T, et al. Marginal ulcer continues to be a major source of morbidity over time following gastric bypass. Surg Endosc. 2019;33(10):3451–6.PubMedCrossRef
37.
Csendes A, Torres J, Burgos AM. Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment. Obes Surg. 2011;21(9):1319–22.PubMedCrossRef
38.
Felix EL, Kettelle J, Mobley E, et al. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc Other Interv Tech. 2008;22(10):2128–32.
39.
Ribeiro-Parenti L, Arapis K, Chosidow D, et al. Comparison of marginal ulcer rates between antecolic and retrocolic laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2015;25(2):215–21.PubMedCrossRef
40.
Edholm D, Sundbom M. Comparison between circular- and linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass - a cohort from the Scandinavian Obesity Registry. Surg Obes Relat Dis. 2015;11(6):1233–6.PubMedCrossRef
41.
Major P, Janik MR, Wysocki M, Walędziak M, Pędziwiatr M, Kowalewski PK. Comparison of circular- and linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass : a multicenter study. 2017;140–146.
42.
Schneider R, Gass J, Kern B, Peters T, Slawik M, Gebhart M, et al. Linear compared to circular stapler anastomosis in laparoscopic Roux-en-Y gastric bypass leads to comparable weight loss with fewer complications : a matched pair study. 2016;307–313.
43.
Brown WA, Johari Y, Shah H, et al. IFSO position statement on the role of esophago-gastro-duodenal endoscopy prior to and after bariatric and metabolic surgery procedures. Obes Surg. 2020;30:3135–53.PubMedCrossRef
44.
Garrido AB, Rossi M, Lima SE, et al. Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment - prospective multicentric study. Arq Gastroenterol. 2010;47(2):130–4.PubMedCrossRef
45.
[Bundesamt für Statistik, BFS, Eidgenössisches Departement des Inneren S. Tabakkonsum in der Schweiz. Schweizerische Gesundheitsbefragung 2017. Bundesamt für Stat. 2017;213–1712:1–8.]
46.
Inokuchi M, Otsuki S, Fujimori Y, et al. Systematic review of anastomotic complications of esophagojejunostomy after laparoscopic total gastrectomy. World J Gastroenterol. 2015;21(32):9656–65.PubMedPubMedCentralCrossRef
47.
Jiang HP, Le Lin L, Jiang X, et al. Meta-analysis of hand-sewn versus mechanical gastrojejunal anastomosis during laparoscopic Roux-en-Y gastric bypass for morbid obesity. Int J Surg. 2016;32:150–7.PubMedCrossRef
48.
Gould JC, Garren M, Boll V, et al. The impact of circular stapler diameter on the incidence of gastrojejunostomy stenosis and weight loss following laparoscopic Roux-en-Y gastric bypass. Surg Endosc Other Interv Tech. 2006;20(7):1017–20.CrossRef
Metadata
Title
Incidence and Prognostic Factors for the Development of Symptomatic and Asymptomatic Marginal Ulcers After Roux-en-Y Gastric Bypass Procedures
Authors
Julian Süsstrunk
Lara Wartmann
Diana Mattiello
Thomas Köstler
Urs Zingg
Publication date
01-07-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 7/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05363-4

Other articles of this Issue 7/2021

Obesity Surgery 7/2021 Go to the issue

Original Contributions

Anthropometric and Biochemical Measures in Bariatric Surgery Candidates: What Is the Role of Inflammatory Potential of Diet?

Letter to the Editor

A Case Report of Subfertility Post Bariatric Surgery—a Rare Yet Significant Complication

Brief Communication

Memory and Executive Function in Adolescent and Young Adult Females with Moderate to Severe Obesity Before and After Weight Loss Surgery

Original Contributions

Is It Possible to Predict Weight Loss After Bariatric Surgery?—External Validation of Predictive Models

Letter to the Editor

Letter to Editor Concerning: Global Bariatric Research Collaborative. Hair Loss After Metabolic and Bariatric Surgery: a Systematic Review and Meta-analysis

Correction

Correction to: Impact of Laparoscopic Sleeve Gastrectomy on Gut Permeability in Morbidly Obese Subjects